Cas:947534-12-5 1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride manufacturer & supplier

Chemical Name:1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride

CAS.NO:947534-12-5

Synonyms:1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride

Molecular Formula:C₈H₁₆ClNS₂

Molecular Weight:225.80200

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:62.63000

Exact Mass:225.04100

LogP:3.06700

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride Use and application,1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride technical grade,usp/ep/jp grade.

Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride manufacturer Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride supplier Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 1,4-dithia-9-azaspiro[4.6]undecane,hydrochloride factory A system that allows Chinese citizens to enter South Korea��s Jeju Island without a visa is to be temporarily suspended.